267 related articles for article (PubMed ID: 31230112)
1. Safety and efficacy of intravenous Colchicine in children with Familial Mediterranean Fever.
Tal R; Semo Oz R; Amarilyo G; Eidlitz-Marcus T; Goldberg O; Levinsky Y; Peled O; Harel L
Rheumatol Int; 2020 Jan; 40(1):121-128. PubMed ID: 31230112
[TBL] [Abstract][Full Text] [Related]
2. Efficacy and safety of long-term treatment with intravenous colchicine for familial Mediterranean fever (FMF) refractory to oral colchicine.
Grossman C; Farberov I; Feld O; Livneh A; Ben-Zvi I
Rheumatol Int; 2019 Mar; 39(3):517-523. PubMed ID: 30604205
[TBL] [Abstract][Full Text] [Related]
3. Familial Mediterranean fever in childhood: a single-center experience.
Barut K; Sahin S; Adrovic A; Sinoplu AB; Yucel G; Pamuk G; Aydın AK; Dasdemir S; Turanlı ET; Buyru N; Kasapcopur O
Rheumatol Int; 2018 Jan; 38(1):67-74. PubMed ID: 28828621
[TBL] [Abstract][Full Text] [Related]
4. Age dependent safety and efficacy of colchicine treatment for familial mediterranean fever in children.
Goldberg O; Levinsky Y; Peled O; Koren G; Harel L; Amarilyo G
Semin Arthritis Rheum; 2019 Dec; 49(3):459-463. PubMed ID: 31255241
[TBL] [Abstract][Full Text] [Related]
5. Intravenous colchicine treatment for six months: adjunctive therapy in familial Mediterranean fever (FMF) unresponsive to oral colchicine.
Rozenbaum M; Boulman N; Feld J; Avshovich N; Petrovich S; Elias M; Slobodin G; Rosner I
Clin Exp Rheumatol; 2009; 27(2 Suppl 53):S105. PubMed ID: 19796546
[No Abstract] [Full Text] [Related]
6. Intravenous colchicine for treatment of patients with familial Mediterranean fever unresponsive to oral colchicine.
Lidar M; Kedem R; Langevitz P; Pras M; Livneh A
J Rheumatol; 2003 Dec; 30(12):2620-3. PubMed ID: 14719203
[TBL] [Abstract][Full Text] [Related]
7. Successful management of colchicine resistant familial Mediterranean fever patients with a standardized canakinumab treatment protocol: a case series and literature review.
Eren Akarcan S; Dogantan S; Edeer Karaca N; Aksu G; Kutukculer N
Rheumatol Int; 2020 Jan; 40(1):161-168. PubMed ID: 31273456
[TBL] [Abstract][Full Text] [Related]
8. Subclinical inflammation in a case of menstruation-induced familial Mediterranean fever: A case report.
Hara K; Endo Y; Ishida M; Fujita Y; Tsuji S; Takatani A; Shimizu T; Sumiyoshi R; Igawa T; Umeda M; Fukui S; Nishino A; Kawashiri SY; Iwamoto N; Ichinose K; Tamai M; Nakamura H; Origuchi T; Migita K; Kawakami A; Koga T
Medicine (Baltimore); 2018 Sep; 97(38):e12305. PubMed ID: 30235678
[TBL] [Abstract][Full Text] [Related]
9. Effect of anti-interleukin-1 treatment on quality of life in children with colchicine-resistant familial Mediterranean fever: A single-center experience.
Kurt T; Aydın F; Nilüfer Tekgöz P; Sezer M; Uncu N; Çelikel Acar B
Int J Rheum Dis; 2020 Jul; 23(7):977-981. PubMed ID: 32558310
[TBL] [Abstract][Full Text] [Related]
10. The Use of Interleukine-1 Inhibitors in Familial Mediterranean Fever Patients: A Narrative Review.
Hentgen V; Vinit C; Fayand A; Georgin-Lavialle S
Front Immunol; 2020; 11():971. PubMed ID: 32670263
[No Abstract] [Full Text] [Related]
11. Comparison of the efficacy and safety of tocilizumab for colchicine-resistant or colchicine-intolerant familial Mediterranean fever: study protocol for an investigator-initiated, multicenter, randomized, double-blind, placebo-controlled trial.
Koga T; Sato S; Miyamoto J; Hagimori N; Kawazoe Y; Arinaga K; Fukushima C; Yamamoto H; Kawakami A
Trials; 2018 Dec; 19(1):715. PubMed ID: 30594222
[TBL] [Abstract][Full Text] [Related]
12. Rilonacept for colchicine-resistant or -intolerant familial Mediterranean fever: a randomized trial.
Hashkes PJ; Spalding SJ; Giannini EH; Huang B; Johnson A; Park G; Barron KS; Weisman MH; Pashinian N; Reiff AO; Samuels J; Wright DA; Kastner DL; Lovell DJ
Ann Intern Med; 2012 Oct; 157(8):533-41. PubMed ID: 23070486
[TBL] [Abstract][Full Text] [Related]
13. Efficacy and safety of interleukin-1 inhibitors in familial Mediterranean fever patients complicated with amyloidosis.
Varan Ö; Kucuk H; Babaoglu H; Guven SC; Ozturk MA; Haznedaroglu S; Goker B; Tufan A
Mod Rheumatol; 2019 Mar; 29(2):363-366. PubMed ID: 29578360
[TBL] [Abstract][Full Text] [Related]
14. Treatment of colchicine-resistant Familial Mediterranean fever in children and adolescents.
Eroglu FK; Beşbaş N; Topaloglu R; Ozen S
Rheumatol Int; 2015 Oct; 35(10):1733-7. PubMed ID: 26001859
[TBL] [Abstract][Full Text] [Related]
15. Canakinumab treatment in four children with colchicine resistant familial mediterranean fever.
Ozkan S; Atas B
J Pak Med Assoc; 2017 Jun; 67(6):945-947. PubMed ID: 28585601
[TBL] [Abstract][Full Text] [Related]
16. Approach to the patients with inadequate response to colchicine in familial Mediterranean fever.
Gül A
Best Pract Res Clin Rheumatol; 2016 Apr; 30(2):296-303. PubMed ID: 27886801
[TBL] [Abstract][Full Text] [Related]
17. Arterial stiffness in Familial Mediterranean Fever: correlations with disease-related parameters and colchicine treatment.
Sgouropoulou V; Stabouli S; Trachana M
Clin Rheumatol; 2019 Sep; 38(9):2577-2584. PubMed ID: 31127463
[TBL] [Abstract][Full Text] [Related]
18. Colchicine is a safe drug in children with familial Mediterranean fever.
Padeh S; Gerstein M; Berkun Y
J Pediatr; 2012 Dec; 161(6):1142-6. PubMed ID: 22738946
[TBL] [Abstract][Full Text] [Related]
19. Do all colchicine preparations have the same effectiveness in patients with familial Mediterranean fever?
Baglan E; Ozdel S; Bulbul M
Mod Rheumatol; 2021 Mar; 31(2):481-484. PubMed ID: 32613873
[TBL] [Abstract][Full Text] [Related]
20. Is age associated with disease severity and compliance to treatment in children with familial Mediterranean fever?
Sönmez HE; Esmeray P; Batu ED; Arıcı ZS; Demir S; Sağ E; Özen S; Bilginer Y
Rheumatol Int; 2019 Jan; 39(1):83-87. PubMed ID: 30088045
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
